Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Communication between the HCCLM3 cells and LX2 cells in a 3D tumor-on-a-chip

ABSTRACT: The communacation between the Hepatocellular carcinoma (HCC) and hepatic stellate cells(HSC) is not completely understood. Then a tumor-on-a-chip model was used to evaluate the crosstalk between the HCC cells (HCCLM3) and HSCs (LX2). After 5 days co-culture, we degraded the collagen hydrogel to isolate HCCLM3 cells and LX2 cells for RNA-seq.

ORGANISM(S): Homo sapiens

PROVIDER: GSE208007 | GEO | 2023/07/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Communication between the HCCLM3 cells and LX2 cells in a 3D tumor-on-a-chip

Project description:Communication between the HCCLM3 cells and LX2 cells in a 3D tumor-on-a-chip

| PRJNA858003 | ENA

Expression data from human hepatic stellate cell line LX2 treated with suberoylanilide hydroxamic acid (SAHA) or valproic acid (VPA)

Project description:Suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA) are both histone deacetylases inhibitor (HDACi), and are able to attenuate the activation of hepatic stelllate cells. To explore the underlying molecular mechanisms, we performed gene expression profile analyses of human hepatic stellate cell line LX2 treated with SAHA or VPA for 24 hours. Duplicate experiments were performed: Untreated LX2, SAHA treated LX2 and VPA treated LX2.

2016-04-07 | E-MTAB-3764 | biostudies-arrayexpress

miRNA expression data from human hepatic stellate cell line LX2 treated with suberoylanilide hydroxamic acid (SAHA) or valproic acid (VPA)

Project description:Suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA ) are both histone deacetylases inhibitor (HDACi), and are able to attenuate the activation of hepatic stelllate cells. To explore the underlying molecular mechanisms, we performed miRNA expression profile analyses of human hepatic stellate cell line LX2 treated with SAHA or VPA for 24 hours. Duplicate experiments were performed: Untreated LX2, SAHA treated LX2 and VPA treated LX2.

2019-07-20 | E-MTAB-6752 | biostudies-arrayexpress

Expression data of LX2 transfected with Adenoviruses overexpressing Gata4 or GFP

Project description:Deactivation of aHSCs has emerged as a novel and promising therapeutic approach for liver fibrosis. However, our knowledge of the master regulators involved in the deactivation of fibrotic HSCs is still limited. The transcription factor GATA4 has been previously shown to play an important role in embryonic hepatic stellate cells quiescence. We aim to evaluate whether GATA4 is able to revert the active phenotype of LX2 cells. Adenoviruses approaches were used to genetically manipulate Gata4 expression in adult hepatic stellate cells. To analyze changes in gene expression mediated by GATA4 we overexpressed Gata4 in LX2 cells and performed Affimetrix analyses

2022-01-07 | GSE168818 | GEO

Recombinant human GDF2 protein effect on human hepatic stellate cell line LX2

Project description:Analysis of human hepatic stellate cell line LX2 stimulated for 24h in serum-free DMEM medium containing 0 or 50 ng/ml recombinant human GDF2 protein. Results provide insight into the activation effects of GDF2 on human hepatic stellate cell. We used microarrays to detail the global programme of gene expression underlying activation of hepatic stellate cells and identified liver-fibrosis-related genes genes during this process.

2019-09-05 | GSE104482 | GEO

Expression data from HepG2 and LX2 cells treated with a dual epigenetic inhibitor of G9A and DNMT1.

Project description:Hepatocarcinogenesis involves epigenetic abnormalities of great relevance. Both the histone methyltransferase G9A and the DNA methyltransferase DNMT1 are overexpressed in fibrosis and liver tumor development. We used microarrays to evaluate the global programme of gene expression in the human HCC cell line HepG2 and in the human Hepatic Stellate Cell LX2, trated with CM272. This molecule is an epigenetic inhibitor that simultaneously targets the methyltransferase activities of G9a and DNMT1.

2021-02-09 | GSE110418 | GEO

Gene expression data of SPC25 KD in HCCLM3 cell line

Project description:Recently, SPC25 was shown to be overexpressed in HCC, but the mechanisms whereby this occurs remain unknown. In this study, we found that SPC25 was significantly overexpressed in HCC tissues, with further analysis revealing that elevated SPC25 expression was associated with HCC prognosis and metastasis. To further explore the mechanism of SPC25 in HCC, we performed a cDNA microarray in SPC25 knockdown HCCLM3 cells.

2022-02-28 | GSE188881 | GEO

The development of microRNA expression profile of human umbilical vein endothelial cells (HUVECs) after exposed to HCCLM3 cells

Project description:we have employed whole microRNA microarray to see the microRNA expression changes of HUVECs after exposed to HCCLM3 cells examine the microRNA expression profile of HUVECs in the absence or presence of human HCC cells

2013-02-22 | E-GEOD-44567 | biostudies-arrayexpress

HCC Cell lines: MHCC97L vs. Huh7 and HCCLM3

Project description:To identify genes associated with HCC invasiveness and metastasis, a hybridization-based microarray assay was used to analyze three cell lines with increasing metastatic potentials, Huh7,MHCC97L, and HCCLM3

2017-04-12 | GSE97626 | GEO

Effect of CTHRC1 knockdown on gene expression of HCCLM3 cells

Project description:Collagen triple helix repeat containing 1 (CTHRC1) has been found to be up-regulated in many human solid tumors. In this study, we investigated the changes of gene expression by comparing CTHRC1-siRNA and Scramble-siRNA control in hepatocellular carcinoma cell line HCCLM3, which has high expression levels of CTHRC1. Differential gene expression was assessed by Affymetrix microarray experiments for 2 samples: CTHRC1-siRNA-treated HCCLM3 cells and Scramble-siRNA-treated HCCLM3 cells.

2012-04-22 | E-GEOD-37208 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data